These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19689616)

  • 1. Differences in medical treatment of chronic coronary heart disease patients according to medical specialities.
    Cordero A; Bertomeu-Martínez V; Mazón P; Quiles J; Aznar J; Bueno H
    Cardiovasc Ther; 2009; 27(3):173-80. PubMed ID: 19689616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile and management of patients with chronic ischemic heart disease according to age in the population daily attended by cardiologists in Spain The ELDERCIC study.
    Barrios V; Escobar C; Murga N; Quijano JJ
    Eur J Intern Med; 2010 Jun; 21(3):180-4. PubMed ID: 20493419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice.
    Connolly P; Cupples ME; Cuene-Grandidier H; Johnston D; Passmore P
    Pharmacoepidemiol Drug Saf; 2002 Jun; 11(4):311-7. PubMed ID: 12138599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.
    Konduracka E; Jóźwiak J; Mastej M; Lukas W; Tykarski A; Szczepaniak-Chicheł L; Piwowarska W
    Przegl Lek; 2008; 65(12):834-7. PubMed ID: 19441674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
    Niu S; Zhao D; Zhu J; Liu J; Liu Q; Liu J; Wang W; Smith SC;
    Am Heart J; 2009 Apr; 157(4):709-15.e1. PubMed ID: 19332200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of risk factors in and treatment of patients with coronary heart disease: the TRECE study.
    Bertomeu V; Cordero A; Quiles J; Mazón P; Aznar J; Bueno H
    Rev Esp Cardiol; 2009 Jul; 62(7):807-11. PubMed ID: 19709516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialty of principal care physician and Medicare expenditures in patients with coronary artery disease: impact of comorbidity and severity.
    McNamara RL; Powe NR; Thiemann DR; Shaffer T; Weller W; Anderson G
    Am J Manag Care; 2001 Mar; 7(3):261-6. PubMed ID: 11258143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study.
    de Rojas FD; De Frutos T; Ponte A; Chacón JM; Vitale GC;
    Prev Cardiol; 2009; 12(2):65-71. PubMed ID: 19476579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care.
    McGovern MP; Boroujerdi MA; Taylor MW; Williams DJ; Hannaford PC; Lefevre KE; Simpson CR
    Fam Pract; 2008 Feb; 25(1):33-9. PubMed ID: 18222938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease management programmes for patients with coronary heart disease--an empirical study of German programmes.
    Gapp O; Schweikert B; Meisinger C; Holle R
    Health Policy; 2008 Dec; 88(2-3):176-85. PubMed ID: 18442868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study.
    Barrios V; Escobar C; Calderón A; Echarri R; González-Pedel V; Ruilope LM;
    J Hum Hypertens; 2007 Jun; 21(6):479-85. PubMed ID: 17314997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary heart disease in China.
    Zhang XH; Lu ZL; Liu L
    Heart; 2008 Sep; 94(9):1126-31. PubMed ID: 18703693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The medical care in internal medicine in relation to consultations].
    García Lázaro M; Lucena Merino MM; Montero Pérez-Barquero M; Sánchez Guijo P
    An Med Interna; 2003 Oct; 20(10):510-4. PubMed ID: 14585036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of patient's age and gender on doctors' decision making about coronary heart disease].
    Bönte M; von dem Knesebeck O; Siegrist J; Marceau L; Link C; McKinlay J
    Dtsch Med Wochenschr; 2007 Oct; 132(43):2251-5. PubMed ID: 17940929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N; Martins S; Belo A; Fiuza M;
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart failure in outpatients: comorbidities and management by different specialists. The EPISERVE Study].
    González-Juanatey JR; Alegría Ezquerra E; Bertoméu Martínez V; Conthe Gutiérrez P; de Santiago Nocito A; Zsolt Fradera I
    Rev Esp Cardiol; 2008 Jun; 61(6):611-9. PubMed ID: 18570782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.